Integrated boost IMRT with FET-PET-adapted local dose escalation in glioblastomas
暂无分享,去创建一个
G. Stoffels | N. Galldiks | K. Langen | M. Eble | M. Pinkawa | M. Piroth | J. Klotz | H. Kaiser | R. Holý | H. Coenen | K. Langen | N. Galldiks | R. Holy | S. Schaar | G. Stoffels | M.D. Piroth | M. Pinkawa | R. Holy | J. Klotz | S. Schaar | H.H. Coenen | H.J. Kaiser | K.J. Langen | M.J. Eble | H. H. Coenen | Hans-Juergen Kaiser
[1] Karl-Josef Langen,et al. O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas. , 2005, Brain : a journal of neurology.
[2] K. Franz,et al. Radiochemotherapy with temozolomide for patients with glioblastoma , 2011, Strahlentherapie und Onkologie.
[3] K. Hamacher,et al. Efficient routine production of the 18F-labelled amino acid O-2-18F fluoroethyl-L-tyrosine. , 2002, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.
[4] R. Sweeney,et al. Prolonged survival when temozolomide is added to accelerated radiotherapy for glioblastoma multiforme , 2011, Strahlentherapie und Onkologie.
[5] Martin J. van den Bent,et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.
[6] K. Walter,et al. Patterns and timing of recurrence after temozolomide-based chemoradiation for glioblastoma. , 2010, International journal of radiation oncology, biology, physics.
[7] Gabriele Stoffels,et al. Prognostic value of early [18F]fluoroethyltyrosine positron emission tomography after radiochemotherapy in glioblastoma multiforme. , 2011, International journal of radiation oncology, biology, physics.
[8] G. Reifenberger,et al. Efficacy and tolerability of temozolomide in an alternating weekly regimen in patients with recurrent glioma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] J. Uhm. Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group , 2010 .
[10] H. Herzog,et al. Prognostic impact of postoperative, pre-irradiation (18)F-fluoroethyl-l-tyrosine uptake in glioblastoma patients treated with radiochemotherapy. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[11] Z. Moravek,et al. 18F-FET-PET-Based Dose Painting by Numbers with Protons , 2010, Strahlentherapie und Onkologie.
[12] M. Walker,et al. An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. , 1979, International journal of radiation oncology, biology, physics.
[13] P. Wen,et al. Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome. , 1999, Journal of neurosurgery.
[14] O. Ratib,et al. Recurrence pattern after [(18)F]fluoroethyltyrosine-positron emission tomography-guided radiotherapy for high-grade glioma: a prospective study. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[15] A. Fiorentino,et al. Single-Arm Phase II Study of Conformal Radiation Therapy and Temozolomide plus Fractionated Stereotactic Conformal Boost in High-Grade Gliomas , 2010, Strahlentherapie und Onkologie.
[16] Morand Piert,et al. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy. , 2004, International journal of radiation oncology, biology, physics.
[17] M. Martel,et al. Patterns of failure following high-dose 3-D conformal radiotherapy for high-grade astrocytomas: a quantitative dosimetric study. , 1999, International journal of radiation oncology, biology, physics.
[18] T. Cascino,et al. Response criteria for phase II studies of supratentorial malignant glioma. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] E. Alexander,et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. , 1978, Journal of neurosurgery.
[20] R. Warnick,et al. Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery. , 2010, International journal of radiation oncology, biology, physics.
[21] F. Heppner,et al. Fractionated stereotactic radiotherapy boost after post-operative radiotherapy in patients with high-grade gliomas. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[22] J. Fowler. The linear-quadratic formula and progress in fractionated radiotherapy. , 1989, The British journal of radiology.
[23] James A. Purdy,et al. Phase I three-dimensional conformal radiation dose escalation study in newly diagnosed glioblastoma: Radiation Therapy Oncology Group Trial 98-03. , 2009, International journal of radiation oncology, biology, physics.
[24] Karl-Josef Langen,et al. O-(2-[18F]fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications. , 2006, Nuclear medicine and biology.
[25] Maria Werner-Wasik,et al. Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol. , 2004, International journal of radiation oncology, biology, physics.
[26] R. Mirimanoff,et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. , 2009, The Lancet. Oncology.
[27] L. Bogner,et al. A Biologically Adapted Dose-Escalation Approach, Demonstrated for 18F-FET-PET in Brain Tumors , 2008, Strahlentherapie und Onkologie.
[28] G. Stoffels,et al. Integrated-boost IMRT or 3-D-CRT using FET-PET based auto-contoured target volume delineation for glioblastoma multiforme - a dosimetric comparison , 2009, Radiation oncology.
[29] Benedick A Fraass,et al. Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] M. Mehta,et al. A phase II trial of accelerated radiotherapy using weekly stereotactic conformal boost for supratentorial glioblastoma multiforme: RTOG 0023 , 2006 .
[31] U Oppitz,et al. 3D-recurrence-patterns of glioblastomas after CT-planned postoperative irradiation. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[32] F. Floeth,et al. Review article O-(2-( 18 F)fluoroethyl)-l-tyrosine: uptake mechanisms and clinical applications , 2006 .